Home
Regulatory Science at FIGON DMD 2018 - Speaker Presentations
Here, you can find the presentations of the RSNN Regulatory Science sessions at the FIGON Dutch Medicines Days on October 1-2, 2018.
Regulatory challenges for the next wave of cancer therapies (9:00-11:00)
- Pauline Evers - Access to innovative cancer therapies: patients view
- Harm Hermsen - Planning for successful and efficient ATMP development
- Marcel Hoefnagel - Regulatory considerations for ATMP based cancer therapies
- Rense ten Ham - Challenges in European Commercial ATMP development
- Sjaak Bot - Regulatory challenges for the next wave of cancer therapies
Evidence generation for innovative products in oncology (14:30-16:30)
- Alwin Otten - Evidence Generation for Innovative Oncology Products Industry Perspective (Janssen)
- Brenda Leeneman - The value of real-world data in reimbursement decisions of oncology drugs
- Jurgen Kuball - The EBMT Registry and CAR-T Cells
- Paula van Hennik - Evidence generation for innovative products in oncology